Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02749890
Brief Title: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (LIXILAN JP-O1)

First Submitted : April 20, 2016
First Submitted that Met QC Criteria : April 22, 2016
First Posted : April 25, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 10, 2018
Last Update Posted : July 11, 2018